Form 4: Mesa Laboratories CEO's Stock Options Expire Unexercised
Insider Transaction Report
Mesa Laboratories' President and CEO, Gary M. Owens, reported the expiration of 9,939 unexercised non-qualified stock options with an exercise price of $203.54 on June 10, 2025.
Summary
- Gary M. Owens, President & CEO of Mesa Laboratories Inc. (MLAB), filed a Form 4 with the SEC.
- The filing reports the expiration of 9,939 non-qualified stock options (NSOs) on June 10, 2025.
- These options had an exercise price of $203.54.
- The options were granted on June 10, 2019, and vested 1/4 on each anniversary date.
- Following this transaction, Mr. Owens beneficially owns 63,830 derivative securities directly.
Sentiment
Score: 3
Explanation: The expiration of a significant number of executive stock options unexercised suggests the company's stock price was below the exercise price, which can be perceived negatively regarding stock performance relative to the strike price.
Negatives
- 9,939 non-qualified stock options held by President & CEO Gary M. Owens expired unexercised on June 10, 2025.
- The expiration of these options, with an exercise price of $203.54, suggests that the company's stock price was likely below this value, rendering the options 'out of the money' and not profitable to exercise.
Future Outlook
NA
Industry Context
This document is a standard insider transaction report (Form 4) and does not provide specific industry context or trends beyond the details of the executive's stock option activity.
Stakeholder Impact
- Shareholders: The expiration of executive stock options unexercised may imply that the company's stock price has not performed sufficiently to make exercising these options profitable, potentially signaling underperformance relative to the strike price.
Key Dates
| Date | Description |
|---|---|
| 06/10/2019 | Grant date of Non-Qualified Stock Options. |
| 06/10/2025 | Expiration date of Non-Qualified Stock Options and transaction date for their disposition. |
| 06/11/2025 | Signature date of the Form 4 filing. |
Keywords
SEC Form 4, Mesa Laboratories, MLAB, stock options, executive compensation, insider transaction, Gary M. Owens, non-qualified stock options, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.